Effect of Thrombolytic Therapy on Pulmonary-Capillary Blood Volume in Patients with Pulmonary Embolism
- 9 October 1980
- journal article
- research article
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 303 (15) , 842-845
- https://doi.org/10.1056/nejm198010093031502
Abstract
To compare the effects of heparin thrombolytic agents in pulmonary thromboembolic disease, we randomly assigned 40 patients with pulmonary emboli but without other clinical cardiopulmonary disease either to heparin followed by oral anticoagulants (21 patients) or to urokinase or streptokinase followed by heparin and then by oral anticoagulants (19 patients). The effects on pulmonary-capillary blood volume and diffusing capacity were compared at two weeks and at one year.This publication has 8 references indexed in Scilit:
- Therapy for Pulmonary EmbolismPublished by American Medical Association (AMA) ,1974
- Urokinase-Streptokinase Embolism TrialJAMA, 1974
- Persistent Post-Embolic Pulmonary HypertensionChest, 1972
- The hemodynamic response to pulmonary embolism in patients without prior cardiopulmonary diseaseThe American Journal of Cardiology, 1971
- Urokinase Therapy in Clinical Pulmonary EmbolismNew England Journal of Medicine, 1967
- The Measurement of Pulmonary Capillary Blood Volume and Pulmonary Membrane Diffusing Capacity in Normal Subjects; The Effects of Exercise and Position12Journal of Clinical Investigation, 1958
- Relative Importance of Diffusion and Chemical Reaction Rates in Determining Rate of Exchange of Gases in the Human Lung, With Special Reference to True Diffusing Capacity of Pulmonary Membrane and Volume of Blood in the Lung CapillariesJournal of Applied Physiology, 1957
- A Standardized Breath Holding Technique for the Clinical Measurement of the Diffusing Capacity of the Lung for Carbon Monoxide 1Journal of Clinical Investigation, 1957